Erratum to “Strategies for Imaging Androgen Receptor Signaling Pathway in Prostate Cancer: Implications for Hormonal Manipulation and Radiation Treatment”

Gravina, Giovanni Luca; Festuccia, Claudio; Bonfili, Pierluigi; Staso, Mario Di; Franzese, Pietro; Ruggieri, Valeria; Popov, Vladimir M.; Tombolini, Vincenzo; Masciocchi, Carlo; Carosa, Eleonora; Lenzi, Andrea; Jannini, Emmanuele A.; Cesare, Ernesto Di

doi:10.1155/2014/437910

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, substantial advances in magnetic resonance spectroscopy, diffusion weighted imaging, dynamic contrast enhanced methods and radiochemistry means that cellular and molecular processes such as angiogenesis, apoptosis, signal transduction and metabolic pathways can now be imaged and this is already becoming increasingly routine in the management of androgen dependent prostate cancer. 88 The prospect of improving our understanding of the underlying pathology, linking it to the genetic variation and understanding the longitudinal evolution of the clinical phenotype as well as its response to therapy will advance considerably as these technologies become more accessible.…”

Section: Imagingmentioning

confidence: 99%

Disorders of sex development: advances in genetic diagnosis and challenges in management

Kyriakou¹,

Lucas‐Herald²,

McGowan³

et al. 2015

AGG

View full text Add to dashboard Cite

Disorders of sex development (DSD) are a group of rare conditions that usually present with atypical genitalia in the newborn period or as delayed puberty in an adolescent. Although a concern about the development of external genitalia may exist in one in 300 newborn infants, discrete genetic conditions that underlie DSD are generally rarely identified. It is likely that this diagnostic gap exists for a number of reasons and these include an inadequate knowledge of the pathogenesis and underlying mechanisms that lead to DSD, variation in assessment and in-depth phenotyping of these rare conditions, inadequate availability of quality accredited laboratories and, lastly, limited awareness of the value of a molecular genetic diagnosis for improving short-term and long-term care of the affected person.

show abstract

Section: Imagingmentioning

confidence: 99%